Aurobindo Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 2,931.94 | 2,845.97 | 2,970.89 |
| Operating Expense | 2,051.83 | 2,135.48 | 2,203.48 |
| Net Profit | 559.13 | 408.17 | 472.05 |
| Net Profit Margin | 19.07 | 14.34 | 15.89 |
| Earning Per Share | 9.63 | 7.03 | 8.13 |
| EBIDTA | 876.83 | 718.39 | 770.55 |
| Effective Tax Rate | 21.32 | 21.85 | 21.37 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 2931.94 |
| Operating Expense | 2051.83 |
| Net Profit | 559.13 |
| Net Profit Margin | 19.07 |
| Earning Per Share | 9.63 |
| EBIDTA | 876.83 |
| Effective Tax Rate | 21.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 10,933.30 | 10,645.64 | 8,457 |
| Operating Expenses Annual | 8,375.73 | 8,421.60 | 6,952.09 |
| Operating Profit Annual | 2,885.69 | 2,894.14 | 1,933.77 |
| Interest Annual | 230.04 | 182.60 | 74.58 |
| Depreciation | 251.79 | 236.72 | 219.12 |
| Net Profit Annual | 1,746.79 | 1,900.10 | 1,242.17 |
| Tax Annual | 611.66 | 502.82 | 388.82 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 10,933.30 |
| Operating Expenses Annual | 8,375.73 |
| Operating Profit Annual | 2,885.69 |
| Interest Annual | 230.04 |
| Depreciation | 251.79 |
| Net Profit Annual | 1,746.79 |
| Tax Annual | 611.66 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 83.32 | 357.13 | 51.13 |
| Cash Flow from Operations | 1,645.79 | 1,714.80 | 1,816.17 |
| Cash Flow from Investing | -2,050.16 | -151.58 | -3,229.65 |
| Cash Flow from Financing | 616.31 | -1,837.03 | 1,719.48 |
| Cash Flow at the End | 295.26 | 83.32 | 357.13 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 83.32 |
| Cash Flow from Operations | 1,645.79 |
| Cash Flow from Investing | -2,050.16 |
| Cash Flow from Financing | 616.31 |
| Cash Flow at the End | 295.26 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 26.39 | 27.19 | 22.87 |
| PBIT Margin (%) | 23.68 | 24.79 | 19.99 |
| PBT Margin (%) | 23.58 | 24.65 | 19.72 |
| Net PROFIT Margin (%) | 15.98 | 18.36 | 14.51 |
| Return On Networth / Equity (%) | 8.68 | 10.35 | 6.98 |
| Return On Networth /Employed (%) | 10.82 | 11.74 | 8.18 |
| Return On Assets (%) | 7.35 | 8.63 | 5.95 |
| Total Debt / Equity (X) | 0.19 | 0.19 | 0.17 |
| Asset Turnover Ratio (%) | 0.46 | 0.47 | 0.41 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 26.39 |
| PBIT Margin (%) | 23.68 |
| PBT Margin (%) | 23.58 |
| Net PROFIT Margin (%) | 15.98 |
| Return On Networth / Equity (%) | 8.68 |
| Return On Networth /Employed (%) | 10.82 |
| Return On Assets (%) | 7.35 |
| Total Debt / Equity (X) | 0.19 |
| Asset Turnover Ratio (%) | 0.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 2,336.80 | 2,419.13 | 3,687.50 |
| Total Current Assets Annual | 7,689.40 | 7,239.13 | 9,964.99 |
| Non Current Assets Annual | 19,823.66 | 17,914.85 | 15,093.82 |
| Total Shareholders Funds Annual | 20,534.11 | 19,722.82 | 18,034.03 |
| Total Assets Annual | 27,513.06 | 25,153.98 | 25,058.81 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 2,336.80 |
| Total Current Assets Annual | 7,689.40 |
| Non Current Assets Annual | 19,823.66 |
| Total Shareholders Funds Annual | 20,534.11 |
| Total Assets Annual | 27,513.06 |
EPS (INR)
Expected
14.20
Reported
14.20
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
